Phase 1B Study of the Pharmacokinetics and Safety of Posaconazole Intravenous Solution in Patients at Risk for Invasive Fungal Disease

This was a phase 1B, dose-ranging, multicenter, pharmacokinetics, and safety study of cyclodextrin-based posaconazole intravenous (i.v.) solution administered through a central line to subjects at high risk for invasive fungal disease (part 1 of a 2-part study [phase 1B/3]). Initially, the safety an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Maertens, Johan, Cornely, Oliver A., Ullmann, Andrew J., Heinz, Werner J., Krishna, Gopal, Patino, Hernando, Caceres, Maria, Kartsonis, Nicholas, Waskin, Hetty, Robertson, Michael N.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2014
Materias:
Pharmacology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4068540/
https://ncbi.nlm.nih.gov/pubmed/24733463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02686-13
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares